NCT05033678 Implementation of Teledermoscopy and Artificial Intelligence
| NCT ID | NCT05033678 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Region Skane |
| Condition | Skin Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 8,000 participants |
| Start Date | 2021-08-16 |
| Primary Completion | 2029-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 8,000 participants in total. It began in 2021-08-16 with a primary completion date of 2029-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study has 2 parts. Part 1 will investigate the effects of introducing teledermoscopy in clinical practice, more specifically the change in referral patterns, the risk of undetected skin cancers and the effect on diagnostic accuracy in general practitioners. Part 2 will investigate how to introduce artificial intelligence (AI) within teledermocsopy. In this study the investigators will measure the diagnostic accuracy of teledermoscopic assessors that had access to the results of artificial intelligence algorithm compared to those who did not. Data will be collected through teledermoscopic referrals, patient records, national registries and questionnairs.
Eligibility Criteria
Inclusion Criteria: * Has a skin lesion assessed by a physician during a visit * The physician decides to create a teledermoscopy referral Exclusion Criteria: * inability or unwillingness to participate in the study * the patient is younger than 15 years old * Images of such bad quality they cannot be assessed
Contact & Investigator
Asa Ingvar, PhD
PRINCIPAL INVESTIGATOR
Department of Dermatology, Skane University Hospital, Region Skane, Sweden
Frequently Asked Questions
Who can join the NCT05033678 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, studying Skin Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05033678 currently recruiting?
Yes, NCT05033678 is actively recruiting participants. Contact the research team at asa.ingvar@skane.se for enrollment information.
Where is the NCT05033678 trial being conducted?
This trial is being conducted at Lund, Sweden.
Who is sponsoring the NCT05033678 clinical trial?
NCT05033678 is sponsored by Region Skane. The principal investigator is Asa Ingvar, PhD at Department of Dermatology, Skane University Hospital, Region Skane, Sweden. The trial plans to enroll 8,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.